Siegfried, a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, announced the transition of its Chief Financial Officer.

As part of a long-term succession process, Tania Micki will join as Chief Financial Officer and member of the Executive Committee, effective July 1, 2026. She will succeed Reto Suter, who has served as CFO since 2017. Reto Suter will ensure a seamless transition during the hand-over period.

Micki joins Siegfried from Tecan Group, where she has served as CFO since 2020.

She brings more than 20 years of experience in finance leadership roles with listed international companies. Prior to Tecan, she held leadership positions at Sulzer, Monsanto and the Gate Group.

Micki has an MBA in general management from the INSEAD Business School (Fontainebleau, France) and graduated from ESCP (École Supérieure de Commerce de Paris), where she specialized in finance, auditing and accounting.